This NDC is on FDA's drug shortage list (posted Mar 26, 2018)
Reported reason: Other
Product Information
KETOROLAC 15 MG/ML VIAL is a generic product labeled by Hospira Inc., priced at $0.9459 per ML under NDC 00409379301. Its NADAC has been published 153 times since May 20, 2015.
FDA first approved this application on Jun 5, 1997. Its Orange Book therapeutic-equivalence code is AP.
Strength
15 mg/mL
Manufacturer
Hospira Inc.NDC
00409379301
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
2/19/2025
Active Ingredients
KETOROLAC TROMETHAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA074802FDA Approved
6/5/1997
TE Code
AP
On Market Since
6/6/2005
Pharmacological Classes
Price Statistics
The NADAC for KETOROLAC 15 MG/ML VIAL has been published 153 times since May 20, 2015, and over the history we have for it it has declined 38.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9459 per ML |
|---|---|
| All-time high | $1.5482 (Jun 15, 2016) |
| All-time low | $0.8912 (Sep 18, 2024) |
| 52-week high | $0.9459 |
| 52-week low | $0.9459 |
| Median price | $0.9569 |
| Average price | $1.1905 |
| Largest weekly change | -21.8% (Jul 17, 2024) |
| Weeks tracked | 153 |
| Tracking since | May 20, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
-38.9%
5Y
-38.9%
All
-38.9%
Last surveyed Feb 11, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of KETOROLAC 15 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 15 MG/ML VIAL, manufactured by Hospira Inc., is $0.9459 per ML (NDC 00409379301), effective Feb 11, 2026.
How has the price of KETOROLAC 15 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for KETOROLAC 15 MG/ML VIAL has declined 38.9%. It has been tracked across 153 weekly CMS publications since May 20, 2015.
What are the highest and lowest recorded NADAC prices for KETOROLAC 15 MG/ML VIAL?
Since May 20, 2015, the NADAC for KETOROLAC 15 MG/ML VIAL has ranged from a low of $0.8912 (Sep 18, 2024) to a high of $1.5482 (Jun 15, 2016), with a median of $0.9569 per ML.
Are there cheaper alternatives to KETOROLAC 15 MG/ML VIAL?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as KETOROLAC 15 MG/ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures KETOROLAC 15 MG/ML VIAL?
KETOROLAC 15 MG/ML VIAL (NDC 00409379301) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Is KETOROLAC 15 MG/ML VIAL in shortage?
Yes — NDC 00409379301 is currently listed in FDA's drug shortage database (posted Mar 26, 2018). Reported reason: Other.